Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
Sep 11, 2012

Top 15 CEO Salaries: Biotech Tool Providers

Find out who's raking in the most in life science gadgetry.

Top 15 CEO Salaries: Biotech Tool Providers

Biotechnology equipment spells big bucks for the industry’s top CEOs. [© ALYUSHIN - Fotolia.com]

  • Below is a list of CEOs of publicly traded companies focused principally on life sciences instrumentation and consumables, ranked by their 2011 total compensation as included in public filings, with comparison to 2010 total compensation. For U.S. companies, the source for compensation figures are the summary compensation tables contained within the DEF 14A proxy statements filed by public companies with the U.S. Securities and Exchange Commission (SEC). For companies headquartered outside the U.S., compensation information is included within Form 20-Fs also filed with SEC.

  • #15. Fluidigm

    Gajus V. Worthington, President and CEO

    2011 Compensation: $1,108,469

    2010 Compensation: $379,555

    % Change: 192.0%

  • #14. Qiagen

    Peer M. Schatz, Managing Director, CEO

    2011 Compensation: $1,845,000

    2010 Compensation: $1,722,000

    % Change: 7.1%

  • #13. Waters

    Douglas A. Berthiaume, Chairman, President, and CEO

    2011 Compensation: $2,646,730

    2010 Compensation: $2,442,165

    % Change: 8.4%

  • #12. Affymetrix

    Frank Witney, Ph.D., President and CEO

    2011 Compensation: $2,739,835

    2010 Compensation: N/A (Appointed July 2011)

    % Change: N/A

  • #11. Sequenom

    Harry F. Hixson Jr., CEO

    2011 Compensation: $3,154,159

    2010 Compensation: $1,052,580

    % Change: 199.7%

  • #10. Bio-Rad Laboratories

    Norman Schwartz, President and CEO

    2011 Compensation: $3,844,998

    2010 Compensation: $3,949,151

    % Change: -2.6%

  • #9. Sigma-Aldrich

    Rakesh Sachdev, President and CEO

    2011 Compensation: $3,915,529

    2010 Compensation: $2,276,031

    % Change: 72.0%

  • #8. Cepheid

    John L. Bishop, CEO and Director

    2011 Compensation: $4,576,225

    2010 Compensation: $3,029,842

    % Change: 51.0%



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »